High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst DE
Blood. 2007 110 (4): 1388-96

PMID: 17452515 · PMCID: PMC1939909 · DOI:10.1182/blood-2007-02-072389

MeSH Terms (21)

Adult Antigens, CD34 Antilymphocyte Serum Combined Modality Therapy Cyclophosphamide Female Fibrosis Follow-Up Studies Granulocyte Colony-Stimulating Factor Hematopoietic Stem Cell Mobilization Hematopoietic Stem Cell Transplantation Humans Immunosuppressive Agents Male Middle Aged Pilot Projects Scleroderma, Systemic Skin Survival Rate Transplantation, Autologous Whole-Body Irradiation

Connections (1)

This publication is referenced by other Labnodes entities: